Applied Pharmaceutical Analysis 2018

Save the Date for the 14th Annual APA Meeting!
October 1-3, 2018

Short Courses September 30th

Sheraton Boston Hotel 
39 Dalton Street 
Boston, MA 02199

APA 2018 Plenary Speakers

		Donna Dambach, VMD, PhD, Senior Director, Head of Toxicology, Safety Assessment, Genentech Safety Lead Optimization: What We Have Learned from Kinase Inhibitors
		Binodh DeSilva, PhD, Head of Analytical Strategy & Operations, Product Development, BMS The Impact of a Reagent Center of Excellence on Bioanalysis, and a Company’s Strategy around Variabilization
		Richard Smith, PhD, Batelle Fellow and Director of Proteome Research, Pacific Northwest National Laboratory New Developments in Ion Mobility-Mass Spectrometry Enabling Improved Higher Throughput and More Sensitive Proteomics and Pan-Omics Measurements for Clinical Diagnostics and Personalized Medicine

APA 2018 Confirmed Speakers

		William Gerwick, PhD, Distinguished Professor of Oceanography and Pharmaceutical Sciences, Director, Center for Marine Biotechnology and Biomedicine, Director, NIH Training Grant on Marine Biotechnology, Co-Director, UC San Diego Center for Compound Resources, Scripps Institution of Oceanography and Skaggs School of Pharmacy and Pharmaceutical Sciences, UC San Diego Antiparasitic Drug Discovery from Marine Cyanobacteria
		Sadik Kassim, PhD, Vice President, Process and Analytical Development, Mustang Bio CAR-T Therapy - Title to be announced
		Jochem Gokemeijer, PhD, Associate Director, Bristol-Myers Squibb ADA - Title to be announced
		Vibha Jawa, PhD, Director Biologics and Vaccine Development, Merck ADA - Title to be announced
		Jun Qu, Professor in Department of Pharmaceutical Sciences, SUNY-Buffalo, and Chief Scientist in Bioanalysis, New York Center of Excellence in Bioinformatics and Life Sciences Sensitive and Robust Trapping-Micro-LC-MS for the Quantification of Biomarkers and Antibody Biotherapeutics
		Dr. Joseph S. Camardo, Senior Vice President Celgene Global Health and Global Medical Affairs, Celgene Attention to Neglected Tropical Diseases: The Impact of the Pharmaceutical Industry and the Mission of Celgene Global Health
		Joseph Cornicelli, Director, In Vivo Cardiovascular and Metabolic Diseases, Inegrated Drug Discovery, Charles River Laboratories NASH - Title to be announced
		Jing-Tao Wu, Vice President, DMPK & Investigative Tox, Alnylam Pharmaceuticals Mechanistic ADME of siRNA-GalNAc Conjugates
		Arindam Dasgupta, Deputy Director, Division of New Drug Bioequivalence, OSIS, OTS, CDER, FDA Common BA/BE Inspection Observations and their Mitigation Strategies
		Sylvia Janetzki, Founder and President, ZellNet Consulting Monitoring the Function of Single Immune Cells – How to Tackle this Daunting Task and Apply Cutting-Edge Developments for Obtaining Meaningful Data

Other confirmed speakers:

Michael F. Skelly, Ph.D., Lead Pharmacologist, Center for Drug Evaluation and Research, Office of Translational Sciences, Office of Study Integrity and Surveillance, U.S. Food and Drug Administration

Christopher Kochansky, Ph.D., Associate Principal Scientist, Merck

Jonathan Bauman, Ph.D., Prinicipal Scientist, Pfizer

Jianwei Shen, Ph.D., Prinicipal Scientist, AbbVie 

Chuck Gu, Ph.D. Prinicipal Scientist, Biotransformation Group Lead, Biogen

Holly Maw,Ph.D., Boehringer Ingelheim

Giovanna Scapin, Ph.D., Prinicipal Scientists, Merck

Guowen Liu, Ph.D., Director of Bioanalyis, Agios

Xiaomin Liang, Ph.D., Research Scientist (DMPK), Gilead Sciences

Proposed Sessions for APA 2018 Workshops 

Regulated Bioanalysis

Regulatory Session / Guidance

Challenges of Immunotherapy in a Regulated Environment

Bioanalytical Support for Novel Therapies

Miscellaneous Topics in Bioanalysis

New Technologies and Applications

Discovery Bioanalysis and New Technologies

Anti-Drug Antibodies (ADA)

Information Technology - Knowledge Management

New Technologies

Omics

Mechanistic ADME

Unusual Metabolites

Toxicity/Safety

Speciality Molecules: Going Beyond the Rule of 5

Software for Met ID

Combined Mechanistic Adme and Discovery Bioanalysis

Role of DMPK in New Modalities

Exploratory Biomarker Analysis

Beyond ADME and Bioanalysis

NASH

CNS

Global Health

Rare/Neglected Diseases

Novel Drug Delivery Systems